GPI

Glucose-6-phosphate isomerase · P06744 · GPI on Sugi Atlas →

0 patent compounds predicted against GPI, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GPI by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety of Empagliflozin in GSD-Ib Patients PHASE2WITHDRAWN
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer PHASE1/PHASE2COMPLETED
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG PHASE2COMPLETED
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients PHASE2ENROLLING_BY_INVITATION
Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy. PHASE2NOT_YET_RECRUITING
Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency PHASE2UNKNOWN
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Plasma Mannose Associated Parameter Levels in Nondiabetic Coronary Artery Disease nanCOMPLETED
The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria nanCOMPLETED
The Natural History of Alpha-Mannosidosis nanCOMPLETED
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation nanCOMPLETED
Evaluation of Blood Protein O-GlcNAcylation Levels in Children nanRECRUITING
Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children nanRECRUITING
The Role of TBC1D4 in Exercise- and Insulin-induced Glucose Metabolism in Human Skeletal Muscle nanCOMPLETED
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE) nanCOMPLETED
Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III) nanCOMPLETED
Study of Glycogen Storage Disease Expression in Carriers nanCOMPLETED
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma nanCOMPLETED
A Real-world, Multi-center, Prospective, Observational Study for PNH in China nanCOMPLETED
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study) nanCOMPLETED
The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS nanCOMPLETED
Clinical Trial Readiness for the Dystroglycanopathies nanRECRUITING
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C nanUNKNOWN
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer nanUNKNOWN
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) nanWITHDRAWN
The Expression Heparanase in Term and Preterm Placentas nanCOMPLETED
GSD VI and GSD IX Natural History nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a GPI binder may also engage these)

ProteinNameSimilarity
Q5R4E3 1.000 Q5R4E3 →
Q4R591 1.000 Q4R591 →
Q3ZBD7 1.000 Q3ZBD7 →
Q9N1E2 1.000 Q9N1E2 →
P06745 0.999 P06745 →
P50309 0.998 P50309 →
Q6P6V0 0.998 Q6P6V0 →
Q2NR04 0.998 Q2NR04 →
P52029 0.996 P52029 →
A7FDG8 0.995 A7FDG8 →
B1JJM7 0.995 B1JJM7 →
Q7MZB4 0.995 Q7MZB4 →
P08059 0.994 P08059 →
A4TH39 0.994 A4TH39 →
A8GKD1 0.993 A8GKD1 →
A9MHA7 0.993 A9MHA7 →
A9R536 0.993 A9R536 →
Q65TC2 0.992 Q65TC2 →
P52031 0.992 P52031 →
B5BJU4 0.992 B5BJU4 →
P52030 0.991 P52030 →
Q1H1P4 0.991 Q1H1P4 →
B4T1R5 0.991 B4T1R5 →
Q1CC27 0.991 Q1CC27 →
Q1CNS4 0.991 Q1CNS4 →
B2K4Y6 0.991 B2K4Y6 →
Q664W9 0.991 Q664W9 →
Q8ZAS2 0.991 Q8ZAS2 →
A9N1J6 0.991 A9N1J6 →
B4TQN8 0.991 B4TQN8 →